Am J Physiol Cell Physiol Ad Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Cell Physiol 292: C372-C382, 2007. First published August 23, 2006; doi:10.1152/ajpcell.00293.2006
0363-6143/07 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
292/1/C372    most recent
00293.2006v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (14)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Judge, A. R.
Right arrow Articles by Kandarian, S. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Judge, A. R.
Right arrow Articles by Kandarian, S. C.

MUSCLE CELL BIOLOGY AND CELL MOTILITY

Role for I{kappa}B{alpha}, but not c-Rel, in skeletal muscle atrophy

Andrew R. Judge,1 Alan Koncarevic,1 R. Bridge Hunter,2 Hsiou-Chi Liou,3 Robert W. Jackman,1 and Susan C. Kandarian1

1Department of Health Sciences, Boston University, Boston; 2Genzyme, Waltham, Massachusetts; and 3Division of Immunology, Department of Medicine, Weill School of Medicine, Cornell University, New York, New York

Submitted 26 May 2006 ; accepted in final form 11 August 2006

Skeletal muscle atrophy is associated with a marked and sustained activation of nuclear factor-{kappa}B (NF-{kappa}B) activity. Previous work showed that p50 is one of the NF-{kappa}B family members required for this activation and for muscle atrophy. In this work, we tested whether another NF-{kappa}B family member, c-Rel, is required for atrophy. Because endogenous inhibitory factor {kappa}B{alpha} (I{kappa}B{alpha}) was activated (i.e., decreased) at 3 and 7 days of muscle disuse (i.e., hindlimb unloading), we also tested if I{kappa}B{alpha}, which binds and retains Rel proteins in the cytosol, is required for atrophy and intermediates of the atrophy process. To do this, we electrotransferred a dominant negative I{kappa}B{alpha} (I{kappa}B{alpha}{Delta}N) in soleus muscles, which were either unloaded or weight bearing. I{kappa}B{alpha}{Delta}N expression abolished the unloading-induced increase in both NF-{kappa}B activation and total ubiquitinated protein. I{kappa}B{alpha}{Delta}N inhibited unloading-induced fiber atrophy by 40%. The expression of certain genes known to be upregulated with atrophy were significantly inhibited by I{kappa}B{alpha}{Delta}N expression during unloading, including MAFbx/atrogin-1, Nedd4, IEX, 4E-BP1, FOXO3a, and cathepsin L, suggesting these genes may be targets of NF-{kappa}B transcription factors. In contrast, c-Rel was not required for atrophy because the unloading-induced markers of atrophy were the same in c-rel–/– and wild-type mice. Thus I{kappa}B{alpha} degradation is required for the unloading-induced decrease in fiber size, the increase in protein ubiquitination, activation of NF-{kappa}B signaling, and the expression of specific atrophy genes, but c-Rel is not. These data represent a significant advance in our understanding of the role of NF-{kappa}B/I{kappa}B family members in skeletal muscle atrophy, and they provide new candidate NF-{kappa}B target genes for further study.

disuse; nuclear factor-{kappa}B signaling; unloading; muscle wasting; ubiquitination; atrophy genes; inhibitory factor {kappa}B{alpha}



Address for reprint requests and other correspondence: S. C. Kandarian, Dept. of Health Sciences, Boston Univ., 635 Commonwealth Ave., 4th Fl., Boston, MA 02215 (e-mail: skandar{at}bu.edu)




This article has been cited by other articles:


Home page
FASEB J.Home page
S. L. Dodd, B. Hain, S. M. Senf, and A. R. Judge
Hsp27 inhibits IKK{beta}-induced NF-{kappa}B activity and skeletal muscle atrophy
FASEB J, October 1, 2009; 23(10): 3415 - 3423.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
D. Van Gammeren, J. S. Damrauer, R. W. Jackman, and S. C. Kandarian
The I{kappa}B kinases IKK{alpha} and IKK{beta} are necessary and sufficient for skeletal muscle atrophy
FASEB J, February 1, 2009; 23(2): 362 - 370.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
W. Li, J. S. Moylan, M. A. Chambers, J. Smith, and M. B. Reid
Interleukin-1 stimulates catabolism in C2C12 myotubes
Am J Physiol Cell Physiol, January 1, 2009; 297(3): C706 - C714.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
S. M. Senf, S. L. Dodd, J. M. McClung, and A. R. Judge
Hsp70 overexpression inhibits NF-{kappa}B and Foxo3a transcriptional activities and prevents skeletal muscle atrophy
FASEB J, November 1, 2008; 22(11): 3836 - 3845.
[Abstract] [Full Text] [PDF]


Home page
PhysiologyHome page
M. Sandri
Signaling in Muscle Atrophy and Hypertrophy
Physiology, June 1, 2008; 23(3): 160 - 170.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
R. A. Frost and C. H. Lang
Protein kinase B/Akt: a nexus of growth factor and cytokine signaling in determining muscle mass
J Appl Physiol, July 1, 2007; 103(1): 378 - 387.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
S. Acharyya and D. C. Guttridge
Cancer Cachexia Signaling Pathways Continue to Emerge Yet Much Still Points to the Proteasome
Clin. Cancer Res., March 1, 2007; 13(5): 1356 - 1361.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2007 by the American Physiological Society.